With support from PITCH, the Cole Lab at UConn is taking a novel approach – instead of targeting the virus, they are targeting the host in their quest to develop a drug to treat the flu.

A joint program with Yale University, PITCH was established in 2016 to encourage commercialization of research from the state’s universities through the discovery of novel drug compounds. The initiative is supported by a three-year, $10 million investment managed by Connecticut Innovations.